| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |